Insights
Insights From Our Experts
Articles
FDA Guidance and Considerations for Scientific Exchange Communication Strategies
In light of draft guidance issued by the U.S. Food and Drug Administration (FDA) regarding the communication of scientific information of unapproved uses (SIUU) of approved medical medical products, EVERSANA continues to assess the potential risk…
Bridging “Share of Voice” with “Share of Influence” for Lasting Impact
In today’s complex healthcare environment, manufacturers must navigate an evolving stakeholder landscape to guarantee patient access and successful product launches. This article explores how deploying a strategic approach that establishes a “share of influence” across the…
Integrated Delivery Networks (IDNs): Driving Change in Drug Access and Utilization
As of May 2024, a striking 77.6% of physicians in the United States are employed by hospitals, health systems and corporate entities – a significant surge from less than 50% a mere decade ago. This trend…
Maximizing Sales Impact in a Hybrid World
In an evolving pharmaceutical landscape, traditional sales methods are giving way to a new hybrid approach. “Maximizing Sales Impact in a Hybrid World” delves into this transformative shift, exploring how data-driven strategies blend personal and non-personal…
Equip FRMs with the Right Tools to Unlock Patient Access
In the modern healthcare landscape, multiple daunting challenges muddy pharmaceutical manufacturers’ ability to ensure patients have timely and uncomplicated access to high-quality care and life-altering medications. A plethora of obstacles can impede the processes of finding…
Future-Proofing Demands Proof: How Innovators Are Transforming Pharma Commercialization
In the fast-evolving landscape of pharmaceuticals, staying ahead demands more than just adapting to today’s challenges – it requires pioneering the future. Introducing intentional innovation, the sweet spot where blue-sky imagination meets on-the-ground effort. It’s being able…
Redefining Field Deployment – Bridging “Share of Voice” with “Share of Influence” for Lasting Impact
In the dynamic realm of pharmaceutical marketing, sales representatives and television commercials remain go-to strategies, skillfully weaving narratives that assure patients of a brand’s therapeutic benefits and persuade providers to alter prescribing habits. Despite their effectiveness,…
There’s a New Way to Omnichannel: Orchestrating Experience to Drive Sales, Savings and Satisfaction
The current state of omnichannel initiatives in the life sciences industry has often been characterized by incremental effectiveness, high costs, complexity, siloed approaches and slow progress. This is not a condemnation of the omnichannel concept, but…
Orchestrating Experiences That Simultaneously Drive Brand Impact and Customer Delight
The evolving landscape of HCP and patient engagement in the pharmaceutical industry necessitates omnichannel solutions that successfully cover multiple touchpoints such as field, web, email, conferences and more. Not only are brands expected to cover these…
Continuous Manufacturing of Pharmaceutical Products: The New Norm
The life sciences sector is changing for the new pharma generation with the introduction of many forms of updated technology and solutions. Continuous manufacturing (CM) is a perfect example. CM is a method for manufacturing pharmaceutical…